Taysha Gene Therapies
TSHA
TSHA
63 hedge funds and large institutions have $411M invested in Taysha Gene Therapies in 2023 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 14 increasing their positions, 6 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
48.17% more ownership
Funds ownership: 21.35% → 69.52% (+48%)
18% more call options, than puts
Call options by funds: $785K | Put options by funds: $663K
Holders
63
Holding in Top 10
3
Calls
$785K
Puts
$663K
Top Buyers
| 1 | +$43.7M | |
| 2 | +$34.5M | |
| 3 | +$31.6M | |
| 4 |
VA
VR Adviser
New York
|
+$27M |
| 5 |
TCM
TCG Crossover Management
Palo Alto,
California
|
+$20.8M |
Top Sellers
| 1 | -$1.15M | |
| 2 | -$827K | |
| 3 | -$775K | |
| 4 |
CC
Carlson Capital
Dallas,
Texas
|
-$320K |
| 5 |
Squarepoint
New York
|
-$97.2K |